Template structure for PPQ sections in Module 3 submissions Template Structure for PPQ Sections in Module 3 Submissions Context The process performance qualification (PPQ) is a critical component in the regulatory submission process, particularly within the context of CMC (Chemistry, Manufacturing, and Controls) documentation. The PPQ protocol and report are essential to demonstrate that a manufacturing process is capable of consistently producing quality product. This article provides a comprehensive guide to the structure of PPQ sections in Module 3 submissions for the US, EU, and UK regulatory environments. Legal/Regulatory Basis Understanding the legal and regulatory basis for PPQ requirements is…

Bridging PPQ Outcomes into Stage 3 CPV Plans in Dossiers Bridging PPQ Outcomes into Stage 3 CPV Plans in Dossiers Process validation is a crucial aspect of pharmaceutical manufacturing, ensuring that processes yield products meeting their predetermined specifications consistently. A key component of this process is the Performance Qualification (PPQ) protocol and report, which are integral to the regulatory submissions related to Chemistry, Manufacturing, and Controls (CMC). This article provides a comprehensive overview of bridging PPQ outcomes into Stage 3 Continued Process Verification (CPV) plans in regulatory dossiers, focusing on expectations from the FDA, EMA, and MHRA. Regulatory Context The…

Use of Statistics in PPQ Data Analysis for Robust CMC Filings Use of Statistics in PPQ Data Analysis for Robust CMC Filings In the pharmaceutical and biotechnology sectors, robust regulatory submissions are paramount for securing market access and ensuring product quality. This article serves as a comprehensive guide for regulatory affairs professionals, focusing on the use of statistics in Performance Qualification Protocols (PPQ) and their associated reports, a critical aspect of Chemistry, Manufacturing, and Controls (CMC) submissions. This guide outlines the regulatory context, documentation requirements, review and approval flows, and common deficiencies identified by regulatory agencies such as the FDA,…

PPQ expectations for biologics versus small molecule submissions PPQ expectations for biologics versus small molecule submissions Regulatory Affairs Context The process of bringing a pharmaceutical product to market is fraught with complexities, particularly regarding regulatory compliance. Within the realm of Regulatory Affairs (RA), the Quality by Design (QbD) principles have gained prominence to ensure that products consistently meet quality standards. A pivotal aspect of this quality framework is the Performance Qualification Protocol (PPQ). The expectations surrounding PPQ protocols and reports for biologics and small molecules vary significantly, influenced by their respective regulatory pathways, product attributes, and manufacturing processes. This article…

Global harmonisation of PPQ documentation across multi-region filings Global Harmonisation of PPQ Documentation Across Multi-Region Filings Context In the field of pharmaceutical and biotechnology development, the process performance qualification (PPQ) plays a crucial role in ensuring that manufacturing processes consistently produce products that meet predefined quality criteria. The adoption of global standards for PPQ documentation and submission is imperative for companies navigating the regulatory landscape across multiple jurisdictions, including the US, EU, and UK. This article provides a comprehensive regulatory explainer manual on PPQ protocols and reports, focusing on stage 2 process validation, and pertinent regulatory expectations. Legal/Regulatory Basis The…